PUMA BIOTECHNOLOGY, INC. — Director's Dealing 2017

Jul 24, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PUMA BIOTECHNOLOGY, INC. (PBYI)
CIK: 0001401667
Period of Report: 2017-07-20

Reporting Person: AUERBACH ALAN H (Director, PRESIDENT AND CEO, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-07-20	COMMON STOCK	S	9175	$94.3439	Disposed	4170623	Direct
2017-07-20	COMMON STOCK	S	4000	$95.60	Disposed	4166623	Direct

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 16, 2016 to satisfy tax obligations in connection with the vesting of restricted stock units.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in two transactions with one transaction pricing at $94.10 and the other transaction pricing at $94.35. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price set forth in this footnote.